Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3846427 | Advances in Chronic Kidney Disease | 2014 | 8 Pages |
Abstract
Kidney transplant recipients are at increased risk for development of malignancy compared with the general population, and malignancies occur at an earlier age. This increased risk, as expressed by the standard incidence ratio (SIR), varies widely, but it is highest in malignancies triggered by oncogenic viruses. For other cancers, this increased risk is the direct consequence of immunosuppressants promoting tumor growth and lowering immune system tumor surveillance. In this review, we briefly discuss the common malignancies with increased risk after kidney transplantation, explore the pros and cons associated with screening, and summarize current prevention and treatment recommendations.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
William S. Asch, Margaret J. Bia,